Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 172 of 1,261
  1. US 11746102

    Polymorphs of selinexor

    Karyopharm Therapeutics Inc. Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  2. US 11745026

    Laser assisted wound healing protocol and system

    THE BIOREGENTECH INSTITUTE, INC. Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  3. US 11744812

    Methods of treatment

    First Wave Bio, Inc. Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  4. US 11744898

    Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods

    Nektar Therapeutics Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  5. US 11744893

    Constrained conditionally activated binding proteins

    Takeda Pharmaceutical Company Limited Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  6. US 11745179

    Microfluidic systems and methods for lipoplex-mediated cell transfection

    The Regents of the University of California Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  7. US 11746126

    Bicyclic peptide ligands with detectable moieties and uses thereof

    BicycleRD Limited Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  8. US 11744892

    Constrained conditionally activated binding proteins

    Takeda Pharmaceutical Company Limited Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  9. US 11746124

    Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates

    Ludwig-Maximilians-Universitat Munchen Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  10. US 11746155

    Cannabinoid receptor type 1 (CB1) binding proteins and uses thereof

    Takeda Pharmaceutical Company Limited Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  11. US 11749394

    Method and apparatus for providing a pharmacokinetic drug dosing regimen

    Takeda Pharmaceutical Company Limited Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  12. US 11746335

    Development of dengue virus vaccine components

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  13. US 11746120

    Stat degraders and uses thereof

    Kymera Therapeutics, Inc. Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  14. US 11746109

    Crystalline forms of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrate

    Takeda Pharmaceutical Company Limited Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  15. US 11744828

    Regimens of tafenoquine for prevention of malaria in malaria-naΓ―ve subjects

    The Government of the United States, as represented by the Secretary of the Army Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  16. US 11746151

    Compositions and methods for treating cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  17. US 11744837

    Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients

    Corcept Therapeutics Incorporated Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  18. US 11744876

    Immunomodulator antibody drug conjugates and uses thereof

    Sutro Biopharma, Inc. Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  19. US 11744873

    Compositions and methods for the treatment of metabolic and liver disorders

    Viking Therapeutics, Inc. Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  20. US 11746152

    Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1

    The Board of Regents of the University of Texas System Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  21. US 11744926

    Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications

    The Board of Regents of the University of Texas System Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  22. US 11744790

    Compositions and methods for blocking ultraviolet radiation

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  23. US 11746087

    C4-carboxylic acid-substituted tryptamine derivatives and methods of using

    Enveric Biosciences Canada Inc. Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted
  24. US 11744800

    Methods of use of emulsion formulations of an NK-1 receptor antagonist

    Heron Therapeutics, Inc. Β· Granted Sep 5, 2023 Β· Expires Aug 31, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.